Giving your fixed income outlook a look? Consider the recent analysis from Morgan Stanley on how it sees the fixed income situation this year. Analysts at the firm assessed the ongoing back-and-forth ...
Narrow-moat CVS Health CVS delivered solid second-quarter results and maintained its 2023 outlook but reduced its 2024 and 2025 goals. Slight changes to our intermediate-term assumptions, which were ...
Raising Merck KGaA's FVE on Strong Near-Term Trends; Shares Rich on Cloudy Intermediate-Term Outlook
After releasing preliminary results about a week ago, narrow-moat Merck KGaA revealed strong third-quarter operating results. We have raised our fair value estimate to EUR 137 based on this near-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results